Phase 3 clinical trial shows comparable improvement in quality of life for children with growth hormone deficiency

A 12-month treatment with either once-weekly somatrogon or once-daily somatropin resulted in comparable improvements in health-related quality of life (HRQoL) among children diagnosed with pediatric growth hormone deficiency (pGHD), according to a study. The study, conducted through a phase 3 clinical trial, utilized the Quality of Life in Short Stature...